RxDoctor Payments Data

Paul Spinner, MD

Family Medicine · Becker, MNNPI 1538141908

Payments from drug & device makers

$388in general payments, 2019–2025

Across 25 payments — averaging $15.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$102
  • Exact Sciences$79
  • Astellas Pharma US Inc$65
  • Novo Nordisk$64
  • Takeda Pharmaceuticals U.S.A., Inc.$26
  • E.r. Squibb & Sons, L.L.C.$13
  • plus $38 from 3 others

What the payments were for

  • Food & beverage$388100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$388 in reported general payments places this provider in the 85th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$77,856
Medicare patients
177
Services billed
1,997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban124$122,996
JardianceEmpagliflozin84$84,710
TrulicityDulaglutide28$47,912
OzempicSemaglutide25$35,709
GlyxambiEmpagliflozin/Linagliptin11$19,311
RybelsusSemaglutide11$15,823
XareltoRivaroxaban13$14,650
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,459
Spiriva RespimatTiotropium Bromide15$10,800
OxycontinOxycodone Hcl11$9,459
TrintellixVortioxetine Hydrobromide12$8,075
Losartan Potassium327$5,855
Atorvastatin Calcium313$5,555
Fluticasone-SalmeterolFluticasone Propion/Salmeterol40$5,342
Rosuvastatin Calcium293$4,715

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi, Spiriva Respimat$102$114,821110 claims
Novo NordiskOzempic, Rybelsus$64$51,53236 claims
Lilly USA, LLCTrulicity$12$47,91228 claims
Johnson & JohnsonXarelto$13$14,65013 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$26$8,07512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in Becker

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →